JP2021515039A5 - - Google Patents
Info
- Publication number
- JP2021515039A5 JP2021515039A5 JP2020567470A JP2020567470A JP2021515039A5 JP 2021515039 A5 JP2021515039 A5 JP 2021515039A5 JP 2020567470 A JP2020567470 A JP 2020567470A JP 2020567470 A JP2020567470 A JP 2020567470A JP 2021515039 A5 JP2021515039 A5 JP 2021515039A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- asthma
- antibody
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862636092P | 2018-02-27 | 2018-02-27 | |
| US62/636,092 | 2018-02-27 | ||
| PCT/US2019/019872 WO2019169015A1 (en) | 2018-02-27 | 2019-02-27 | Anti cd6 antibodies for treating severe asthma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021515039A JP2021515039A (ja) | 2021-06-17 |
| JP2021515039A5 true JP2021515039A5 (enExample) | 2022-03-07 |
| JP7572041B2 JP7572041B2 (ja) | 2024-10-23 |
Family
ID=65724591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020567470A Active JP7572041B2 (ja) | 2018-02-27 | 2019-02-27 | 重症喘息を処置するための組成物および方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20210380711A1 (enExample) |
| EP (1) | EP3759140A1 (enExample) |
| JP (1) | JP7572041B2 (enExample) |
| KR (1) | KR20200128415A (enExample) |
| CN (1) | CN112424226B (enExample) |
| AU (1) | AU2019228508A1 (enExample) |
| BR (1) | BR112020017445A2 (enExample) |
| CA (1) | CA3091920A1 (enExample) |
| IL (1) | IL276875A (enExample) |
| MX (1) | MX2020008916A (enExample) |
| PH (1) | PH12020551323A1 (enExample) |
| SG (1) | SG11202008149RA (enExample) |
| WO (1) | WO2019169015A1 (enExample) |
| ZA (1) | ZA202005320B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009113083A1 (en) | 2008-03-14 | 2009-09-17 | Biocon Limited | A monoclonal antibody and a method thereof |
| EP3024485B1 (en) | 2013-07-23 | 2020-11-18 | Biocon Limited | Use of a cd6 binding partner and method based thereon |
| ES2991182T3 (es) | 2016-10-21 | 2024-12-02 | Biocon Ltd | Un anticuerpo monoclonal y un método de uso para el tratamiento del lupus |
| US20230151107A1 (en) * | 2020-04-04 | 2023-05-18 | Biocon Limited | Anti-cd6 antibody compositions and methods for treating and reducing negative effects of a coronavirus including covid-19 |
| JP2023552762A (ja) * | 2020-12-04 | 2023-12-19 | エクイリウム，インコーポレイテッド | Ｃｄ６ｈｉｇｈ細胞を選択的に標的化してｔｅｆｆ細胞の活性を低下する方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5462990A (en) * | 1990-10-15 | 1995-10-31 | Board Of Regents, The University Of Texas System | Multifunctional organic polymers |
| CU22615A1 (es) | 1994-06-30 | 2000-02-10 | Centro Inmunologia Molecular | Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos |
| CU22584A1 (es) * | 1995-11-17 | 1999-11-03 | Centro Inmunologia Molecular | Composiciones farmacéuticas que contienen un anticuerpo monoclonal que reconoce el antígeno de diferenciación leucocitario humano cd6 y sus usos para el diagnóstico y tratamiento de la psoriasis |
| WO1998043089A1 (en) | 1997-03-03 | 1998-10-01 | Bristol-Myers Squibb Company | Monoclonal antibodies to human cd6 |
| KR101482959B1 (ko) | 2006-12-26 | 2015-01-15 | 센트로 데 인뮤놀러지아 모레큘러 | Ｂ-세포 만성 림프구성 백혈병의 진단 및 치료에 유용한 종양 세포에서 세포사멸을 유도할 수 있는 약학 조성물 |
| WO2009113083A1 (en) | 2008-03-14 | 2009-09-17 | Biocon Limited | A monoclonal antibody and a method thereof |
| CN102559636B (zh) * | 2011-12-30 | 2014-03-12 | 百泰生物药业有限公司 | 用于白血病和自身免疫疾病的抗体融合蛋白及其制备方法 |
| JP6296650B2 (ja) * | 2013-03-13 | 2018-03-20 | 国立大学法人 筑波大学 | 免疫疾患に対する医薬組成物 |
| UA117608C2 (uk) * | 2014-02-21 | 2018-08-27 | Дженентек, Інк. | Спосіб лікування еозинофільного захворювання у пацієнта шляхом застосування біспецифічного анти-il-13/il-17 антитіла |
| KR20180030030A (ko) * | 2015-07-15 | 2018-03-21 | 교와 핫꼬 기린 가부시키가이샤 | 인간 crth2에 특이적으로 결합하는 항체 |
| US10562975B2 (en) * | 2016-06-15 | 2020-02-18 | The Regents Of The University Of Michigan | CD6 antibody for treatment of T-cell mediated diseases or disorders |
| JP7065085B2 (ja) * | 2016-10-18 | 2022-05-11 | バイオコン・リミテッド | Ｃｄ６のリン酸化を低減させるためのイトリズマブの使用 |
-
2019
- 2019-02-27 CN CN201980027155.5A patent/CN112424226B/zh active Active
- 2019-02-27 SG SG11202008149RA patent/SG11202008149RA/en unknown
- 2019-02-27 US US16/976,298 patent/US20210380711A1/en not_active Abandoned
- 2019-02-27 CA CA3091920A patent/CA3091920A1/en active Pending
- 2019-02-27 WO PCT/US2019/019872 patent/WO2019169015A1/en not_active Ceased
- 2019-02-27 MX MX2020008916A patent/MX2020008916A/es unknown
- 2019-02-27 EP EP19710274.2A patent/EP3759140A1/en active Pending
- 2019-02-27 AU AU2019228508A patent/AU2019228508A1/en not_active Abandoned
- 2019-02-27 BR BR112020017445-9A patent/BR112020017445A2/pt not_active IP Right Cessation
- 2019-02-27 KR KR1020207027953A patent/KR20200128415A/ko not_active Ceased
- 2019-02-27 JP JP2020567470A patent/JP7572041B2/ja active Active
-
2020
- 2020-08-23 IL IL276875A patent/IL276875A/en unknown
- 2020-08-25 PH PH12020551323A patent/PH12020551323A1/en unknown
- 2020-08-26 ZA ZA2020/05320A patent/ZA202005320B/en unknown
-
2024
- 2024-06-10 US US18/739,089 patent/US20250034272A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021515039A5 (enExample) | ||
| EP2500361B1 (en) | Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof | |
| EP4198055A1 (en) | Antibody of il-11 and use thereof | |
| JP2022023051A (ja) | 瘻孔を伴うクローン病の治療用ベドリズマブ | |
| US9067996B2 (en) | Antibodies to receptor for advanced glycation end products (RAGE) and uses thereof | |
| CN110624107A (zh) | 通过施用il-4r拮抗剂治疗或预防哮喘的方法 | |
| JP2014511179A5 (enExample) | ||
| JP2017507945A5 (enExample) | ||
| JP2024541680A5 (enExample) | ||
| HUE031923T2 (en) | Antibody molecules that exhibit binding specificity for human IL-13 | |
| JP2019513726A5 (enExample) | ||
| EP2986640B1 (en) | Humanized antibody against interleukin-20 and treatment for inflammatory diseases | |
| WO2020034941A1 (zh) | 抗IL-1β的抗体、其药物组合物及其用途 | |
| JP2021511024A5 (enExample) | ||
| JP2024525870A (ja) | 抗ｐｌａ２ｒ自己抗体媒介膜性腎症の治療 | |
| TW202235435A (zh) | 抗cd38抗體及其用途 | |
| US20260008865A1 (en) | Antibodies, compositions, and methods of treatment | |
| WO2021139687A1 (zh) | 抗cd47抗体和抗cd20抗体的组合在制备用于预防或治疗肿瘤的药物中的应用 | |
| CN118076640A (zh) | 抗-pla2r自身抗体介导的膜性肾病的治疗 | |
| EP4511396A1 (en) | Antibodies and methods targeting interleukin-19 | |
| RU2020130563A (ru) | Антитела к cd6 для лечения тяжелой астмы | |
| TH1901006538A (th) | การบำบัดโรคหอบหืดด้วยแอนติบอดี้ต้าน tslp | |
| NZ619873A (en) | Methods and compositions for treating asthma using anti-il-13 antibodies | |
| HK1137182B (en) | Antibodies to receptor of advanced glycation end products (rage) and uses thereof |